Neuroequilibrium Diagnostic Systems Profile
Key Indicators
- Authorised Capital ₹ 1.55 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.36 M
as on 16-11-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.25 Cr
as on 16-11-2024
- Revenue 82.06%
(FY 2023)
- Profit -1.04%
(FY 2023)
- Ebitda -2.41%
(FY 2023)
- Net Worth 86.51%
(FY 2023)
- Total Assets 36.18%
(FY 2023)
About Neuroequilibrium Diagnostic Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.55 Cr and a paid-up capital of Rs 0.36 M.
The company has closed loans amounting to ₹1.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajneesh Bhandari and Anita Bhandari serve as directors at the Company.
- CIN/LLPIN
U33110RJ2015PTC047281
- Company No.
047281
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2015
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Neuroequilibrium Diagnostic Systems Private Limited offer?
Neuroequilibrium Diagnostic Systems Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Neuroequilibrium Diagnostic Systems?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajneesh Bhandari  | Managing Director | 28-Mar-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anita Bhandari | Director | 28-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Neuroequilibrium Diagnostic Systems.
Neuroequilibrium Diagnostic Systems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.06% increase. The company also saw a slight decrease in profitability, with a 1.04% decrease in profit. The company's net worth Soared by an impressive increase of 86.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuroequilibrium Diagnostic Systems?
In 2023, Neuroequilibrium Diagnostic Systems had a promoter holding of 99.82% and a public holding of 0.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Futurecure Health Private LimitedActive 5 years 7 monthsRajneesh Bhandari and Anita Bhandari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Sep 2021 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Neuroequilibrium Diagnostic Systems?
Neuroequilibrium Diagnostic Systems has a workforce of 97 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuroequilibrium Diagnostic Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuroequilibrium Diagnostic Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
